Loading chat...
OH HCR34
Concurrent Resolution
Status
10/13/2021
Primary Sponsor
Brian Stewart
Click for details
AI Summary
-
Urges Ohio's congressional delegation to investigate McKinsey & Company's role in the opioid crisis and its conflicts of interest with federal agencies
-
Cites Ohio's more than 23,000 opioid-related overdose deaths from 2010-2019 and McKinsey's strategies to "turbocharge" OxyContin sales for pharmaceutical clients
-
Notes Ohio joined 47 other states in a lawsuit resulting in McKinsey paying nearly $600 million in settlement
-
Alleges McKinsey simultaneously advised the FDA to streamline drug approval processes while advising pharmaceutical clients on how to circumvent FDA review
-
Calls for action to prevent conflicts of interest in federal contracting involving McKinsey at the FDA, Department of Defense, Department of Veterans Affairs, and other agencies
Legislative Description
Urge Congress investigate McKinsey & Co. conflicts of interest.
Health and Human Services : Public Health
Last Action
Introduced and Referred to Committee: Government Oversight
10/13/2021